Medtronic (MDT) Stock Forecast & Price Target

Compare

6,304 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MDT Analyst Ratings

Moderate Buy

9 Buy

11 Hold

0 Sell

Based on 20 analysts giving stock ratings to

Medtronic

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MDT Stock 12 Month Forecast

Average Price Target

$110.00

▲(9.63% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $110.00 with a high forecast of $119.00 and a low forecast of $90.00. The average price target represents a 9.63% change from the last price of $100.34.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"77":"$77","120":"$120","87.75":"$87.8","98.5":"$98.5","109.25":"$109.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":119,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$119.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[77,87.75,98.5,109.25,120],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,90.7,92.87692307692308,95.05384615384615,97.23076923076923,99.40769230769232,101.58461538461539,103.76153846153846,105.93846153846154,108.11538461538461,110.2923076923077,112.46923076923076,114.64615384615385,116.82307692307693,{"y":119,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,90.7,92.18461538461538,93.66923076923077,95.15384615384616,96.63846153846154,98.12307692307692,99.6076923076923,101.0923076923077,102.57692307692308,104.06153846153846,105.54615384615384,107.03076923076924,108.51538461538462,{"y":110,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,90.7,90.64615384615385,90.5923076923077,90.53846153846155,90.48461538461538,90.43076923076923,90.37692307692308,90.32307692307693,90.26923076923077,90.21538461538462,90.16153846153846,90.1076923076923,90.05384615384615,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":87.2,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.78,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.01,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.69,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.86,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.42,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.08,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.67,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.63,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.81,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$119.00

Average Price Target$110.00

Lowest Price Target$90.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt Miksic

Barclays

$111

Buy

10.62%

Upside

Reiterated

11/20/25

Barclays Sticks to Its Buy Rating for Medtronic (MDT)

Joanne Wuensch

Citi

$112→$117

Buy

16.60%

Upside

Reiterated

11/19/25

Medtronic price target raised to $117 from $112 at CitiMedtronic price target raised to $117 from $112 at Citi

David Rescott

Robert W. Baird

$103→$109

Hold

8.63%

Upside

Reiterated

11/19/25

Medtronic price target raised to $109 from $103 at BairdMedtronic price target raised to $109 from $103 at Baird

Larry Biegelsen

Wells Fargo

$100→$114

Buy

13.61%

Upside

Reiterated

11/19/25

Medtronic price target raised to $114 from $100 at Wells FargoMedtronic price target raised to $114 from $100 at Wells Fargo

Lee Hambright

Bernstein

$98→$111

Buy

10.62%

Upside

Reiterated

11/19/25

Bernstein Keeps Their Buy Rating on Medtronic (MDT)We rate Medtronic Outperform with a price target of $111 (up from $98) using a forward P/E multiple of 17.5x.

Danielle Antalffy

UBS

$95→$102

Hold

1.65%

Upside

Reiterated

11/19/25

Cautious Hold Rating on Medtronic Amid Mixed Segment Performance and Uncertain Growth Prospects

Patrick Wood

Morgan Stanley

$107→$117

Buy

16.60%

Upside

Reiterated

11/19/25

Medtronic price target raised to $117 from $107 at Morgan StanleyMedtronic price target raised to $117 from $107 at Morgan Stanley

David Roman

Goldman Sachs

$111

Hold

10.62%

Upside

Upgraded

11/19/25

Analysts Offer Insights on Healthcare Companies: LifeMD (NASDAQ: LFMD) and Medtronic (NYSE: MDT)Medtronic Plc (MDT): 2025 | 4:31PM PST | Research | Equity We upgrade shares of Medtronic (MDT) from Sell to Neutral post 2QFY26 results, as the company's new product momentum picks up and overall P&L metrics take another step in the right direction. Across all metrics, the most notable to us in the accelerated growth in R&D and SG&A, setting the stage for more durable performance, in our view. Simply put, we now see clear evidence of the company's strategy translating into execution. From a valuation perspective, MDT trades at 17.1x our revised CY2026E EPS vs. large cap diversified healthcare comps at ~20.4x (~10x on the low-end to ~29x on the high-end).

Brandon Vazquez

William Blair

―

Hold

―

Reiterated

11/19/25

Medtronic's Strategic Growth and Cautious Optimism Amid Fiscal Gains and Investment Needs

Travis Steed

Bank of America Securities

$100→$115

Buy

14.61%

Upside

Reiterated

11/18/25

Medtronic price target raised to $115 from $100 at BofAMedtronic price target raised to $115 from $100 at BofA

Brian Abrahams

RBC Capital

$111→$118

Buy

17.60%

Upside

Reiterated

11/18/25

Analysts Are Bullish on These Healthcare Stocks: Alkermes (ALKS), Medtronic (MDT)

Rick Wise

Stifel Nicolaus

$105

Hold

4.64%

Upside

Reiterated

11/18/25

Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME) and Medtronic (NYSE: MDT)We rate Medtronic shares Hold.

Josh Jennings

TD Cowen

$106→$119

Buy

18.60%

Upside

Reiterated

11/18/25

Medtronic's Strong Financial Performance and Growth Potential Justifies Buy Rating

Lila Implantra

TR | OpenAI - 4o

$101→$111

Buy

10.62%

Upside

Reiterated

11/18/25

AI Generated ArticleAI Generated Article

Michael Matson

Needham

―

Hold

―

Reiterated

11/18/25

Medtronic's Mixed Performance: Hold Rating Amid Revenue Growth and Margin ConcernsWe believe that MDT is in the early stages of a strong product cycle, and we are encouraged by its improved growth in F2Q26, but we maintain our Hold rating until there are more signs that its organic growth is seeing meaningful, and sustainable, acceleration.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt Miksic

Barclays

$111

Buy

10.62%

Upside

Reiterated

11/20/25

Barclays Sticks to Its Buy Rating for Medtronic (MDT)

Joanne Wuensch

Citi

$112→$117

Buy

16.60%

Upside

Reiterated

11/19/25

Medtronic price target raised to $117 from $112 at CitiMedtronic price target raised to $117 from $112 at Citi

David Rescott

Robert W. Baird

$103→$109

Hold

8.63%

Upside

Reiterated

11/19/25

Medtronic price target raised to $109 from $103 at BairdMedtronic price target raised to $109 from $103 at Baird

Larry Biegelsen

Wells Fargo

$100→$114

Buy

13.61%

Upside

Reiterated

11/19/25

Medtronic price target raised to $114 from $100 at Wells FargoMedtronic price target raised to $114 from $100 at Wells Fargo

Lee Hambright

Bernstein

$98→$111

Buy

10.62%

Upside

Reiterated

11/19/25

Bernstein Keeps Their Buy Rating on Medtronic (MDT)We rate Medtronic Outperform with a price target of $111 (up from $98) using a forward P/E multiple of 17.5x.

Danielle Antalffy

UBS

$95→$102

Hold

1.65%

Upside

Reiterated

11/19/25

Cautious Hold Rating on Medtronic Amid Mixed Segment Performance and Uncertain Growth Prospects

Patrick Wood

Morgan Stanley

$107→$117

Buy

16.60%

Upside

Reiterated

11/19/25

Medtronic price target raised to $117 from $107 at Morgan StanleyMedtronic price target raised to $117 from $107 at Morgan Stanley

David Roman

Goldman Sachs

$111

Hold

10.62%

Upside

Upgraded

11/19/25

Brandon Vazquez

William Blair

―

Hold

―

Reiterated

11/19/25

Medtronic's Strategic Growth and Cautious Optimism Amid Fiscal Gains and Investment Needs

Travis Steed

Bank of America Securities

$100→$115

Buy

14.61%

Upside

Reiterated

11/18/25

Medtronic price target raised to $115 from $100 at BofAMedtronic price target raised to $115 from $100 at BofA

Brian Abrahams

RBC Capital

$111→$118

Buy

17.60%

Upside

Reiterated

11/18/25

Analysts Are Bullish on These Healthcare Stocks: Alkermes (ALKS), Medtronic (MDT)

Rick Wise

Stifel Nicolaus

$105

Hold

4.64%

Upside

Reiterated

11/18/25

Analysts Offer Insights on Healthcare Companies: Zymeworks (NASDAQ: ZYME) and Medtronic (NYSE: MDT)We rate Medtronic shares Hold.

Josh Jennings

TD Cowen

$106→$119

Buy

18.60%

Upside

Reiterated

11/18/25

Medtronic's Strong Financial Performance and Growth Potential Justifies Buy Rating

Lila Implantra

TR | OpenAI - 4o

$101→$111

Buy

10.62%

Upside

Reiterated

11/18/25

AI Generated ArticleAI Generated Article

Michael Matson

Needham

―

Hold

―

Reiterated

11/18/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

1 Month

xxx

Success Rate

13/22 ratings generated profit

Average Return

+1.78%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +1.78% per trade.

3 Months

xxx

Success Rate

17/22 ratings generated profit

Average Return

+4.37%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +4.37% per trade.

1 Year

Travis SteedBank of America Securities

Success Rate

23/28 ratings generated profit

Average Return

+6.51%

reiterated a buy rating 3 days ago

Copying Travis Steed's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +6.51% per trade.

2 Years

xxx

Success Rate

26/28 ratings generated profit

Average Return

+12.19%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 92.86% of your transactions generating a profit, with an average return of +12.19% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDT Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MDT has received 30 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. MDT average Analyst price target in the past 3 months is 110.00.

Each month's total comprises the sum of three months' worth of ratings.

MDT Financial Forecast

MDT Earnings Forecast

Next quarter’s earnings estimate for MDT is $1.34 with a range of $1.33 to $1.36. The previous quarter’s EPS was $1.36. MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Sales Forecast

Next quarter’s sales forecast for MDT is $8.90B with a range of $8.83B to $9.01B. The previous quarter’s sales results were $8.96B. MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?

Based on analyst ratings, Medtronic’s 12-month average price target is 110.00.

What is MDT’s upside potential, based on the analysts’ average price target?

Medtronic has 9.63% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MDT a Buy, Sell or Hold?

Medtronic has a consensus rating of Moderate Buy which is based on 9 buy ratings, 11 hold ratings and 0 sell ratings.

What is Medtronic’s price target?

The average price target for Medtronic is 110.00. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $119.00 ,the lowest forecast is $90.00. The average price target represents 9.63% Increase from the current price of $100.34.

What do analysts say about Medtronic?

Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of MDT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Medtronic (MDT) Stock Forecast & Price Target

MDT Analyst Ratings

MDT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Medtronic

MDT Analyst Recommendation Trends

MDT Financial Forecast

MDT Earnings Forecast

MDT Sales Forecast

MDT Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts